WRF
AGN.PRA

Waddell & Reed Financial’s Allergan plc AGN.PRA Stock Holding History

Waddell & Reed Financial’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-30,000
Closed -$17.6M – 583
2017
Q4 		$17.6M Sell
30,000
-47,500
-61% -$30.7M 0.04% 354
2017
Q3 		$57.2M Hold
77,500
– – 0.13% 195
2017
Q2 		$67.3M Sell
77,500
-4,400
-5% -$3.69M 0.15% 178
2017
Q1 		$69.6M Sell
81,900
-3,230
-4% -$2.68M 0.15% 174
2016
Q4 		$64.9M Sell
85,130
-6,200
-7% -$4.69M 0.14% 182
2016
Q3 		$75M Buy
91,330
+9,000
+11% +$7.78M 0.16% 164
2016
Q2 		$68.6M Buy
82,330
+30,580
+59% +$25.5M 0.14% 170
2016
Q1 		$47.6M Buy
51,750
+2,250
+5% +$2.15M 0.09% 207
2015
Q4 		$51M Buy
49,500
+14,500
+41% +$14.6M 0.08% 205
2015
Q3 		$33M Hold
35,000
– – 0.05% 255
2015
Q2 		$36.5M Buy
+35,000
New +$36.6M 0.05% 261

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return

Waddell & Reed Financial's AGN.PRA Position: Q1 2018 in Review

Waddell & Reed Financial sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 30,000 shares — an estimated $17.6M sold.

Waddell & Reed Financial first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $75M in Q3 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Waddell & Reed Financial reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Waddell & Reed Financial sold 30,000 Allergan plc shares in Q1 2018, an estimated $17.6M.
  • Waddell & Reed Financial first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Waddell & Reed Financial's Allergan plc position peaked at $75M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Waddell & Reed Financial's 13F filing for Q1 2018, filed 15 May 2018.